KalVista Pharmaceuticals
KALV
KALV
24 hedge funds and large institutions have $63.2M invested in KalVista Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
+6
Holders Change %
+33.33%
% of All Funds
0.55%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
11
Increased
4
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$8.29M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$3.05M |
| 3 |
Millennium Management
New York
|
+$2.31M |
| 4 |
NC
Nexthera Capital
New York
|
+$1.76M |
| 5 |
Renaissance Technologies
New York
|
+$865K |
Top Sellers
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$18.3M |
| 2 |
VMI
VHCP Management II
New York
|
-$1.49M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$793K |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$146K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$75K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BFM
26
Boothbay Fund Management
New York
| – | -$146K | -21,665 | Closed |
|
|
27
Alyeska Investment Group
Chicago,
Illinois
| – | -$75K | -11,184 | Closed |
|
|
PAM
28
Panagora Asset Management
Boston,
Massachusetts
| – | -$15K | -2,274 | Closed |
|